Product image of Auromemo (Memantine Hydrochloride) supplied by GNH India

Auromemo

Active Ingredient:
Memantine Hydrochloride
Origin:
EU

Auromemo (Memantine Hydrochloride)

Auromemo is a medication containing Memantine Hydrochloride, used for managing moderate to severe dementia. This oral medication is designed to support cognitive function and may improve daily living activities.

Manufacturer / TM Owner

Aurovitas Pharma Polska Sp. Z O.O

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Auromemo is primarily used to treat moderate to severe dementia, including Alzheimer's disease. Memantine Hydrochloride works by regulating glutamate activity in the brain, which can help improve memory, attention, and overall cognitive function. People often ask, 'What is Auromemo used for?' It is commonly prescribed to slow the progression of symptoms associated with dementia and enhance the quality of life for patients.

Side Effects

  • Common effects of Auromemo may include headaches, dizziness, and constipation. Some users might experience fatigue or confusion. These effects vary among individuals and are generally mild. If any side effects persist or worsen, it is advisable to consult a healthcare professional.

Precautions & Warnings

  • Auromemo should be handled with care, especially for individuals with a history of seizures or liver problems. It is important to follow the prescribed dosage and administration instructions. Pregnant or breastfeeding women should consult a healthcare provider before using this medication.

Avoid Interactions

  • Auromemo may interact with other medications, including those that affect the central nervous system. Alcohol consumption should be avoided as it can enhance the sedative effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Auromemo is used to manage moderate to severe dementia, including Alzheimer's disease, by improving cognitive function and daily living activities.

Auromemo is taken orally, typically once a day. Follow the dosage instructions provided by your healthcare professional.

Common side effects may include headaches, dizziness, constipation, fatigue, and confusion. These effects are usually mild but should be monitored.

Auromemo may interact with other medications, especially those affecting the central nervous system. Always consult your healthcare provider before combining medications.

Pregnant or breastfeeding women should consult a healthcare provider before using Auromemo to ensure safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Memantine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT